LFVN as of Nov 2 · 00:12 ET
LFVNNasdaqPharmaceutical Preparations
Lifevantage Corp · Brief
Next report
1 day
Nov 3 · after closeest.Q1 FY27
Expected move
Inputs0 of 8≥ implied
- avg implied
- ±26.7%
- avg realized
- ±9.1%
Oct 29 '24±21.8%▼−0.39%×0.02
Feb 5 '25±31.6%▼−16.49%×0.52
May 6 '25±32.4%▼−6.60%×0.20
Sep 4 '25±32.7%▼−10.03%×0.31
Nov 4 '25±23.6%▲+4.43%×0.19
Q2 FY26±21.3%▼−16.76%×0.79
Q3 FY26±24.5%▼−16.33%×0.67
Q4 FY26±25.2%▼−1.47%×0.06
quarterimplied−35%0+35%realized×
Q4 FY26±25.2%▼−1.47%×0.06
Q3 FY26±24.5%▼−16.33%×0.67
Q2 FY26±21.3%▼−16.76%×0.79
Nov '25±23.6%▲+4.43%×0.19
Sep '25±32.7%▼−10.03%×0.31
May '25±32.4%▼−6.60%×0.20
2 older reports
Feb '25±31.6%▼−16.49%×0.52
Oct '24±21.8%▼−0.39%×0.02
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 3 report · est.Bull1
Bear2 of 3
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
LFVN report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.